Works about CARBOPLATIN


Results: 1802
    1
    2
    3

    The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14252-3
    By:
    • Yıldırım, Sedat;
    • Başoğlu, Tugba;
    • Doğan, Akif;
    • Akdağ, Goncagul;
    • Kınıkoğlu, Oguzcan;
    • Topal, Alper;
    • Alan, Ozkan;
    • Solmaz, Ali Alper;
    • Gürbüz, Mustafa;
    • Çil, Timucin;
    • Çolak, Rumeysa;
    • Yılmaz, Mesut;
    • Kalem, Ali;
    • Sever, Nadiye;
    • Majıdova, Nargiz;
    • Karakoyun, Kubilay;
    • Sekmek, Serhat;
    • Saçlı, Omer;
    • Ozcelık, Melike;
    • Işık, Deniz
    Publication type:
    Article
    4
    5
    6
    7
    8

    Carboplatin desensitization in the era of target therapies: still worthwhile?

    Published in:
    Child's Nervous System, 2024, v. 40, n. 12, p. 4259, doi. 10.1007/s00381-024-06564-9
    By:
    • Dassi, Natália;
    • da Cunha, Fernanda Sales;
    • Cappellano, Andrea Maria;
    • de Araujo, Chayanne Andrade;
    • de Aquino, Denise Neiva Santos;
    • de Almeida, Daniela Barbosa;
    • da Silva, Nasjla Saba;
    • Ensina, Luis Felipe Chiaverini
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15

    Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors.

    Published in:
    2001
    By:
    • Warren, Katherine E.;
    • Patel, Mahendra C.;
    • Aikin, Alberta A.;
    • Widemann, Brigitte;
    • Libucha, Madeleine;
    • Adamson, Peter C.;
    • Neuwirth, Rachel;
    • Benziger, David;
    • O'Toole, Timothy;
    • Ford, Kathleen;
    • Patronas, Nicholas;
    • Packer, Roger J.;
    • Balis, Frank M.;
    • Warren, K E;
    • Patel, M C;
    • Aikin, A A;
    • Widemann, B;
    • Libucha, M;
    • Adamson, P C;
    • Neuwirth, R
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21

    Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies.

    Published in:
    NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00369-w
    By:
    • Alhalabi, Omar;
    • Groisberg, Roman;
    • Zinner, Ralph;
    • Hahn, Andrew W.;
    • Naing, Aung;
    • Zhang, Shizhen;
    • Tsimberidou, Apostolia M.;
    • Rodon, Jordi;
    • Fu, Siqing;
    • Yap, Timothy A.;
    • Hong, David S.;
    • Sun, Ming;
    • Jiang, Yunfang;
    • Pant, Shubham;
    • Shah, Amishi Y.;
    • Zurita, Amado;
    • Tannir, Nizar M.;
    • Vikram, Raghunandan;
    • Roszik, Jason;
    • Meric-Bernstam, Funda
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29

    Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis.

    Published in:
    Annals of the American Thoracic Society, 2024, v. 21, n. 4, p. 635, doi. 10.1513/AnnalsATS.202311-941OC
    By:
    • Ikeda, Satoshi;
    • Ogura, Takashi;
    • Kato, Terufumi;
    • Kenmotsu, Hirotsugu;
    • Agemi, Yoko;
    • Tokito, Takaaki;
    • Ito, Kentaro;
    • Isomoto, Kohsuke;
    • Takiguchi, Yuichi;
    • Yoneshima, Yasuto;
    • Yokoyama, Toshihide;
    • Harada, Toshiyuki;
    • Tanzawa, Shigeru;
    • Kobayashi, Nobuaki;
    • Iwasawa, Tae;
    • Misumi, Toshihiro;
    • Okamoto, Hiroaki
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    SALL4 is a new target in endometrial cancer.

    Published in:
    Oncogene, 2015, v. 34, n. 1, p. 63, doi. 10.1038/onc.2013.529
    By:
    • Li, A;
    • Jiao, Y;
    • Yong, K J;
    • Wang, F;
    • Gao, C;
    • Yan, B;
    • Srivastava, S;
    • Lim, G S D;
    • Tang, P;
    • Yang, H;
    • Tenen, D G;
    • Chai, L
    Publication type:
    Article
    47
    48
    49

    An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 1, p. 195, doi. 10.4143/crt.2016.376
    By:
    • Shin-Wha Lee;
    • Yong-Man Kim;
    • Chi Heum Cho;
    • Young Tae Kim;
    • Seok Mo Kim;
    • Soo Young Hur;
    • Jae-Hoon Kim;
    • Byoung-Gie Kim;
    • Seung-Cheol Kim;
    • Hee-Sug Ryu;
    • Soon Beom Kang
    Publication type:
    Article
    50